Igor Smolenov
Arcturus Therapeutics (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Bacterial Infections and Vaccines, Viral gastroenteritis research and epidemiology, Influenza Virus Research Studies, Pneumonia and Respiratory Infections
Most-Cited Works
- → mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials(2019)456 cited
- → Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial(2021)280 cited
- → A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults(2020)146 cited
- → Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study(2009)142 cited
- → Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial(2022)113 cited
- → Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults(2022)80 cited
- → Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life(2011)78 cited
- → Horizontal transmission of a human rotavirus vaccine strain—A randomized, placebo-controlled study in twins(2011)78 cited
- → Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials(2024)69 cited
- → Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Preterm European Infants(2012)65 cited